Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-11 4:00 pm Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 2,262,026 5.100% |
-2,065,596 (-47.73%) |
Filing History |
| 2024-01-23 4:09 pm Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 4,327,622 9.800% |
458,230 (+11.84%) |
Filing History |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,869,392 8.800% |
3,869,392 (New Position) |
Filing History |
| 2022-02-10 5:29 pm Sale |
2021-12-31 | 13G | DarioHealth Corp. DRIO |
Soleus Capital Special Opportunities Fund, L.P. | 0 0.000% |
-401,606 (Position Closed) |
Filing History |
| 2022-02-10 5:27 pm Purchase |
2021-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,525,457 8.010% |
50,799 (+1.46%) |
Filing History |
| 2021-02-12 4:01 pm Purchase |
2020-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 3,474,658 9.990% |
630,471 (+22.17%) |
Filing History |
| 2020-08-03 12:56 pm Purchase |
2020-07-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 2,844,187 9.990% |
721,214 (+33.97%) |
Filing History |
| 2020-07-31 5:20 pm Purchase |
2020-07-31 | 13G | DarioHealth Corp. DRIO |
Soleus Capital Special Opportunities Fund, L.P. | 401,606 5.620% |
401,606 (New Position) |
Filing History |